medigraphic.com
ISSN 2078-7162 (Print)

2011, Number 1

<< Back Next >>

Rev Cub de Med Fis y Rehab 2011; 3 (1)

Effects of the electromagnetic field-based therapy in levels of fatigue of patients with multiple sclerosis

López PYM, Pavón FN, Bravo AT, Gómez LA, Cabrera GJA, Martínez AG

Language: Spanish
References: 42
Page:
PDF size: 125.47 Kb.


ABSTRACT

Objective: To evaluate the electromagnetic field-based treatment for fatigue caused by multiple sclerosis. Material and method: A prospective, explanatory, experimental and longitudinal study was conducted in 36 patients with fatigue, who had been examined and diagnosed with multiple sclerosis at the Psychomotor Evaluation Laboratory of the International Center of Neurological Restoration. To this end, the modified Fatigue Impact Scale (FIS) was used before and after treatment with the Cuban 1750-1 magnetic bed (50 gauss intensity) applied to the whole body for 20 minutes. The Kolmogorov-Sminov statistical tests verified the normal distribution whereas the Chi-Square test served to check the variance homogeneity; in such cases where the latter was achieved, t-test was used for the comparison and the level of significance was p ‹ 0.05. Results: the sample was composed of women (83.3%) aging 20 to 40 years. The progressive secondary clinical form was the most frequent, with moderate fatigue intensity and 6 months and over of evolution. Fatigue was one of the most disabling symptoms in those patients. The application of low-frequency electromagnetic fields reduced the fatigue intensity, that is, the physical cognitive and psychosocial fatigue. Conclusions: the electromagnetic field-based treatment increases the efficacy of the neurorehabilitating treatment of multiple sclerosis patients with fatigue.


REFERENCES

  1. Fernández O, Fernández VE. Esclerosis múltiple. Madrid: Fundación Española de Esclerosis Múltiple, 2000.

  2. Tola MA, Yugueros MI, Fernández BN, Fernández HR. Impacto de la fatiga en la esclerosis múltiple: estudio de una serie de base poblacional en Valladolid. Rev Neurol 1998; 26: 930-3.

  3. Djaldetti R, Ziv I, Achiron A, Melamed E. Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment. Neurology 1996; 46: 632-5.

  4. Tola MA, Yugueros MI, Fernández BN, Marco J, Gutiérrez GJ, Gómez NJ et al. Deficiencia, discapacidad y minusvalía en la esclerosis múltiple: un estudio de base poblacional en Valladolid. Rev Neurol 1998; 26: 728-34.

  5. Izquierdo G, Ruiz Peña JL. Evaluación clínica de la esclerosis múltiple: cuantificación mediante la utilización de escalas. Rev Neurol 2003; 36 (2): 145-52.

  6. Sandyk R. Bidirectional effect of electromagnetic fields on ketanserin- induced yawning in patients with multiple sclerosis: the role of melatonin. Int J Neurosci 1996; 85: 93-9.

  7. Rudick RA, Barna BP. Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue. Arch Neurol 1990; 47: 254-5.

  8. Lloyd A, Hickie I, Hickie C, Dwyer J, Wakefield D. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol 1992; 87: 76-9.

  9. Mohr K, Coyle PK, Krupp LB, Doschler C. Serial immune changes in multiple sclerosis patiens under treatment for fatigue. Neurology 1992; 42(Suppl 3), 384.

  10. Moreau T, Coles A, Wing M, Isaacs J, Hale G, Waldmann H et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996; 119: 225-37.

  11. Olek MJ, Hohol MJ, Khoury SJ, Dawson DM, Hafler DA, Weiner HL. Multiple sclerosis: Therapeutic overview. In Cook SD, ed. Handbook of multiple sclerosis. New York: Marcel Dekker; 1996. p. 377-96.

  12. Tellez N, Rio J, Tintore M, Nos C, Galan I, Montalban X. Does the modified fatigue impact scale offer a more comprehensive assessment of fatigue in MS? Mult Scler. 2005 Apr; 11(2):198-202.

  13. Schwid SR, Covington M, Segal BM, Goodman AD. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev. 2002; 39:211-24.

  14. Krupp LB, LaRocca NG, Muir Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-3.

  15. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18 (Suppl 1): S79-83.

  16. Rubira Zaragoza.: Magnetoterapia. En: Medicina Física. España, Cap. 22.1999.

  17. Branas P, Jordan R, Fry-Smith A, Burls A, Hyde C. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technology Assessment 2000; 4(27):1-61.

  18. Martín Cordero JE. Agentes físicos terapéuticos. La Habana: ECIMED, 2008.

  19. Jerabek J. Pulsed magnetotherapy in Czechoslovakia. A review. Rev Environ Health 1994; 10(2):127-34.

  20. Yurkiv L. The Use of changeable magnetic field in treatment of osteoarthrosis, european bioelectromagnetics association, 3rd International Congress, 29 February-3 March 1996, Nancy, France.

  21. Sandyk R. Resilution of Disarthria in Múltiple Sclerosis Treatment with Weak Electromagnetic Field. Int J Neurosci 1995; 83(1-2): 81-92.

  22. Sandyk R. ¨Further Observations on the Effect of external pico tesla range magnetic fields on visual memory and visuospacial functions in múltiple sclerosis,¨ International Journal of Neurosci, 77 (3-4), August 1994, 203-27.

  23. Martín Cordero JE, García Delgado JA. Introducción a la magnetoterapia. La Habana. CIMEQ, 2002. 51 p.

  24. Sandyk R. Rapid Sandyk R. Premenstrual exsacerbation of symtoms in múltiple sclerosis attenuated by treatment with weak electromagnetic field. International Journal of Neurosci, 1195; 83(3-4):187-98.

  25. Sandyk R. ¨Reversal of alexia in múltiple sclerosis by weak electromagnetic field¨. International Journal of Neurosci, 83(1-2), November 1995, pp. 69-79.

  26. Sandyk R. Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis: guidelines. International Journal of Neurosci 1996; 84: 177-86.

  27. Hadjimichael O, Vollmer T, Oleen-Burkey M. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008, 6:100.

  28. Colosimo C, Millefiorini E, Grasso MG, Vinci F, Fiorelli M, Koudriavtseva T et al. Fatigue in MS is associated with specific clinical features. Acta Neurol Scand 1995; 92: 353-5.

  29. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patient with multiple sclrerosis. Can J Neurol Sci 1994; 21: 9-14.

  30. Alarcia R, Ara JR, Martin J, Bertol V, Bestué M. Importancia y factores relacionados con la fatiga crónica en la esclerosis múltiple. Neurología 2005; 20(2):77-84.

  31. Bakshi R, Miletich RS, Henschel K, et al. Fatigue in multiple sclerosis: crosssectional correlation with brain MRI findings in 71 patients. Neurology. 1999; 53: 1151-3.

  32. kroencke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler 2000; 6:131-6.

  33. Iriarte J, Subira ML, Castro P. Modalities of fatigue in multiple sclerosis: correlation whith clinical and biological factors. Mult Scler 2000; 6: 124-30.

  34. Kesselring J, Klement U. Cognitive and affective disturbances in multiple sclerosis. J Neurol. 2001; 248:1803.

  35. Varany K,Gessi S, Merighi S, Iannotta V, Cattabriga E, Spisani S, Cadossi R, ? Borea P.A. Effect of low frecuency electromagnetic field on A2A adenosina receptor in human neutrophils, British Journal of Pharmacology 2002; 136(1): 57-66.

  36. Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y et al. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Arch Neurol 2004; 61: 201-7.

  37. Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an Example of Cytokine Mediated Sickness Behaviour?. J Neurol Neurosurg Psychiatry 2006; 77(1):34-9.

  38. Vercoulen JH, Hommes OR, Swanink CM, Jongen PJ, Fennis JF,Galama JM, Meer JW van der, Bleijenberg G: The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996, 53:642-9.

  39. Lappin MS, Lawaie FW, Richards TL, Kramer ED. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life a double-blind, placebo controlled trial. Altern Ther Health Med 2003; 9: 38-48.

  40. Nielsen JF, Sinkjaer T, Jakobson J. Treatment of spasticity with repetitive magnetic stimulation: a double blind placebo-controlled study. Mult Scler 1996; 2: 227-32.

  41. Mostert S, Kesselring. Effect of pulsed magnetic field therapy on the level of fatigue in patients with multiple sclerosis a randomized controlled trial. Mult Scler 2005; 302-5.

  42. Salzberg CA, et al. The effects of non-thermal pulsed electromagnetic energy on wound healing of pressure ulcers in spinal cord- injured patients: A randomized, double-blind study, wounds: a compendium of clinical research and practice, 7 (1), 1995; 11-6.




2020     |     www.medigraphic.com